Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 745-754
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.745
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.745
Figure 4 Cumulative patient survival classified by the number of risk factors.
Risk factors were Child-Pugh score > 5, presence of arterio-venous shunt, amount of lipiodol used > 7 mL during transarterial chemoembolization (TACE), and female gender.
- Citation: Kim HC, Suk KT, Kim DJ, Yoon JH, Kim YS, Baik GH, Kim JB, Kim CH, Sung H, Choi JY, Han KH, Park SH. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. World J Gastroenterol 2014; 20(3): 745-754
- URL: https://www.wjgnet.com/1007-9327/full/v20/i3/745.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.745